IDiyas

For the Inventor, By the Inventor

Santa Ana, CA, United States of America

Gyorgy F Ambrus

USPTO Granted Patents = 12 

 

 

Average Co-Inventor Count = 3.4

ph-index = 4

Forward Citations = 48(Granted Patents)


Location History:

  • Tustin, CA (US) (1994)
  • Santa Ana, CA (US) (2009 - 2020)

Company Filing History:

goldMedal12 out of 2,285 
 
Allergan, Inc.
 patents

Years Active: 1994-2020

Loading Chart...
Loading Chart...
Loading Chart...
12 patents (USPTO):Explore Patents
1. 10668081 - Prostamide-containing intraocular implant (2020-06-02),
2. 9889142 - Prostamide-containing intraocular implant (2018-02-13),
3. 9540328 - (−)-(2R,3S)-2-amino-3-hydroxy-3-pyridin-4-yl-1-pyrrolidin-1-yl-propan-1-one (L)-(+) tartrate salt, its method of production and use (2017-01-10),
4. 9387196 - 3-{1-[5-chloro-2-(2-ethylbutoxy)benzyl]-5-methyl-1H-pyrazol-3-yl}propanoic acid in crystalline form and methods for use thereof (2016-07-12),
5. 9353079 - Solid forms of an alpha, omega di-substituted dihydroxy cyclopentyl compound and methods for the preparation and use thereof (2016-05-31),
6. 9321717 - Process for rapid identification and preparation of crystalline forms (2016-04-26),
7. 9289413 - Prostamide-containing intraocular implant (2016-03-22),
8. 9242935 - (-)-(2R,3S)-2-amino-3-hydroxy-3-pyridin-4-yl-1-pyrrolidin-1-yl-propan-1-one (L)-(+) tartrate salt, its method of production and use (2016-01-26),
9. 9181176 - [object Object] (2015-11-10),
10. 8629185 - 7-[3,5-dihydroxy-2- (3-hydroxy-5-phenyl-pent-1-enyl)-cyclopentyl]-N-ethyl-hept-5-enamide (bimatoprost) in crystalline form II, methods for preparation, and methods for use thereof (2014-01-14),
11. 7491383 - Compositions having enhanced pharmacokinetic characteristics (2009-02-17),
12. 5276044 - Leukotriene receptor antagonist and antihistamine complex pharmaceutical (1994-01-04),

Title: Unveiling the Innovations of Inventor Gyorgy F Ambrus

Introduction:

Inventor Gyorgy F Ambrus is a prominent figure in the field of ophthalmic innovations, hailing from Santa Ana, California. With an impressive portfolio of 12 patents to his name, he has made significant contributions to the medical industry, particularly in the realm of intraocular implants and glaucoma treatment.

Latest Patents:

Gyorgy F Ambrus's latest patents revolve around prostamide-containing intraocular implants. These biodegradable implants, along with prostamide compounds and pharmaceutical compositions, aim to provide immediate and sustained reduction of intraocular pressure for the treatment of glaucoma patients. His groundbreaking work showcases his dedication to advancing ocular care and enhancing patient outcomes.

Career Highlights:

Currently affiliated with Allergan, Inc., Gyorgy F Ambrus thrives in an environment that fosters innovation and collaboration. His tenure at Allergan, Inc. has allowed him to bring his inventive ideas to life and address unmet needs in the field of ophthalmology. Through his patents and research, he has solidified his reputation as a pioneering inventor in the medical community.

Collaborations:

Inventor Gyorgy F Ambrus has had the privilege of working alongside esteemed colleagues such as Ke Wu and David Frederick Woodward. This collaborative spirit has undoubtedly fueled his creativity and facilitated the development of groundbreaking technologies that benefit patients worldwide. Together, they have propelled the field of ophthalmic innovation to new heights.

Conclusion:

In conclusion, Gyorgy F Ambrus's commitment to excellence and his relentless pursuit of groundbreaking solutions have reshaped the landscape of ophthalmic care. His impressive portfolio of patents stands as a testament to his ingenuity and dedication to improving the lives of individuals affected by glaucoma. As he continues to push the boundaries of medical innovation, the future undoubtedly holds more exciting discoveries from this visionary inventor.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…